Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021
Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …

News

US Congress to investigate FDA’s approval of Biogen’s Alzheimer’s drug

September 3, 2021
Medical Communications

The US Congress has requested data and documents from the FDA in relation to its accelerated approval of the controversial …

News

Purdue pharma to pay billions for opioid pandemic but gains immunity in deal

September 2, 2021

A US judge has approved Purdue Pharma’s, the makers of Oxycontin, reorganisation plan, which will offer them immunity from any …

News

Risk of long COVID halved by vaccines, study finds

September 2, 2021
Medical Communications

Researchers at King’s College London have found that being fully vaccinated against COVID-19 not only cuts the risk of catching …

News

Moderna recall COVID vaccines after stainless steel contaminants found

September 2, 2021
Medical Communications

Moderna and Takeda Pharmaceutical on Wednesday said they are working with Japanese authorities to recall three batches of their COVID-19 …

News

FDA seeks new warnings on arthritis drugs

September 2, 2021
Medical Communications

The FDA has requested that Pfizer, Eli Lilly, and AbbVie include additional warnings on their arthritis drugs about the risks …

News
moderna_norwood_plant

Moderna submits data to FDA for COVID-19 vaccine booster

September 2, 2021

Moderna has initiated its submission to the FDA for the evaluation of a booster dose of the Moderna COVID-19 vaccine. …

News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021
Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …

News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021
Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …

News
annie-spratt-yiiz4olewg4-unsplash_1

AI test screens for COVID-19 26% faster than lateral flow tests

September 1, 2021
Research and Development

A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …

News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021
Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …

News

NICE approves life-saving cholesterol drug for NHS

September 1, 2021
Research and Development

NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …

News

Empagliflozin demonstrates significant improvement in heart failure outcomes

August 31, 2021
Manufacturing and Production

Empagliflozin (Jardiance) showed a significant 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalisation for …

News
sanofi_hq__boetie_hall_web

Dupilumab significantly reduces atopic dermatitis in children

August 31, 2021
Manufacturing and Production

A pivotal Phase III trial evaluating dupilumab for the treatment of children aged six months to five years with moderate-to-severe …

News
clinical_trials_2

Bone Therapeutics knee osteoarthritis Phase III study misses primary endpoints

August 31, 2021
Manufacturing and Production

Bone Therapeutics, the cell therapy company addressing unmet medical needs in orthopaedics and other diseases, announced that the Phase III …

News
hand-3666974_1280

AlzeCure’s Alzheimer’s project receives approval to start phase I study

August 31, 2021
Manufacturing and Production

AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of candidate drugs for diseases affecting the central nervous …

News

New Zealand woman dies after receiving Pfizer COVID vaccine

August 31, 2021
Manufacturing and Production

New Zealand has reported what they believe to be the first death associated with the Pfizer vaccine. An independent vaccine …

News

Blood-clot risk “substantially higher” from COVID than from jabs

August 27, 2021
Medical Communications

The risks of developing a blood clot are “substantially higher” after catching coronavirus than following a COVID vaccine, research shows. …

News

UCB’s bimekizumab granted marketing authorisation by MHRA for plaque psoriasis

August 27, 2021
Medical Communications

UCB’s bimekizumab has been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA)  for the treatment of …

News

NICE rejects combination treatment for multiple myeloma

August 27, 2021
Medical Communications

NICE does not recommend daratumumab (Darzalex, Janssen Cilag), plus bortezomib, thalidomide and dexamethasone, as a treatment option for untreated multiple …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025